AstraZeneca could face limited fallout from Chinese tax probe
逃税风波下 阿斯利康manbetx3.0 营收仍创新高

The drugs giant and one of its top executives are being investigated over business tactics in China, but a potential fine for one alleged offence would not break the bank
事件的主角之一，很可能是此前因“配合调查”而消失于公众视野的阿斯利康前manbetx3.0 区总裁王磊。